Results 21 to 30 of about 75,950 (297)
Pulmonary Surfactants for Acute and Chronic Lung Diseases (Part I)
Part 1 of the review gives information on the composition and properties of a pulmonary surfactant and quantitative and qual itative impairments in the pulmonary surfactant system in different neonatal and adult abnormalities and describes the ...
O. A. Rozenberg
doaj +1 more source
During postnatal adaptation pulmonary surfactant may be inactivated by lipopolysaccharide (LPS). We evaluated the effect of surfactant therapy in combination with antibiotic polymyxin B (PxB) in double-hit model of neonatal lung injury.
Andrea Calkovska +2 more
doaj +1 more source
Pulmonary effects of inhalation of spark-generated silver nanoparticles in Brown-Norway and Sprague-Dawley rats [PDF]
The increasing use of silver nanoparticles (AgNPs) in consumer products is concerning. We examined the potential toxic effects when inhaled in Brown-Norway (BN) rats with a pre-inflammatory state compared to Sprague-Dawley (SD) rats.We determined the ...
Buckley, A +17 more
core +1 more source
Short-term Outcome of Pulmonary Hemorrhage in Very-Low-Birth-Weight Preterm Infants
Severe pulmonary hemorrhage is a serious complication with a high mortality rate in preterm infants with respiratory distress syndrome (RDS) after surfactant therapy.
Ting-An Yen +5 more
doaj +1 more source
Changes in the Activity of the Pulmonary Surfactant after Contact with Bentonite Nanoclay Particles
Nanoclays are used as fillers in the production of polymer nanocomposites. They contribute to improving the physical, heat and resistance properties of nanocomposites.
D. Kondej, T. Sosnowski
doaj +1 more source
Methane (CH4) exerted protective effects against lung ischemia-reperfusion (I/R) injury, but the mechanism remains unclear, especially the role of pulmonary surfactant.
Bing Zhang +7 more
doaj +1 more source
Lung surfactant alterations in pulmonary thromboembolism
Beside neonatal respiratory distress syndrome, secondary surfactant deficiency may occur in patients with mature lungs. Recent studies revealed quantitative and qualitative changes of lung surfactant in pulmonary thromboembolism (PTE) concerning the ...
Calkovska A, Mokra D, Calkovsky V
doaj +1 more source
Single Versus Multiple Doses of Surfactant Treatment in Preterm Infants
Aim:Exogenous surfactant may be needed not only for Respiratory Distress syndrome (RDS) treatment; but also, in the management of other pulmonary diseases of infants.
Betül Siyah Bilgin +5 more
doaj +1 more source
Gene Therapy Potential for Genetic Disorders of Surfactant Dysfunction
Pulmonary surfactant is critically important to prevent atelectasis by lowering the surface tension of the alveolar lining liquid. While respiratory distress syndrome (RDS) is common in premature infants, severe RDS in term and late preterm infants ...
Ashley L. Cooney +6 more
doaj +1 more source
Engineering novel complement activity into a pulmonary surfactant protein [PDF]
Complement neutralizes invading pathogens, stimulates inflammatory and adaptive immune responses, and targets non- or altered-self structures for clearance.
Anthony H. Keeble +38 more
core +2 more sources

